NEW YORK (GenomeWeb) – WuXi AppTec is partnering with Fudan University to bring WuXi NextCode's population genomics database system and integrated research and clinical solutions to researchers at the Fudan-led Collaborative Innovation Center of Genetics and Development (CICGD).
According to the partners, CICGD scientists will use the NextCode technology to accelerate research, clinical diagnosis, and treatment of rare inherited diseases and malignant tumors.
NextCode offers integrated turnkey solutions that support research-centric analyses, clinical interpretation, and diagnostic test development and delivery. The system is currently being used to analyze and manage whole-genome data on 350,000 people, more than any other system in use today, according to NextCode.
Established in 2012, the CICGD brings together several Chinese research institutions in addition to Fudan University, including Shanghai Jiaotong University, Nanjing University, Zhongshan University, Central South University, the Shanghai Institutes for Biological Sciences, the Institute of Genetics and Developmental Biology, and the Beijing Institute of Genomics.
The current partnership will help to bring "the latest technological and medical advances closer to patients in China and around the world," Ge Li, chairman and CEO of WuXi AppTec, said in a statement. "We are delighted to partner with Fudan University … to promote genomics research and its applications," he added.
Financial and other terms of the agreement were not disclosed.